Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Shortage reports
Actual shortage:
1 (1%)
Anticipated shortage:
0 (0%)
Avoided shortage:
5 (4%)
Resolved:
115 (95%)
121
Discontinuation Reports
To be discontinued:
2 (15%)
Discontinued:
9 (69%)
Reversed:
2 (15%)
13
6 (4%)
2 (67%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2020-09-11 | 2020-10-24 | 124122 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2019-12-07 | 2020-02-05 | 100498 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2019-10-24 | 2019-11-08 | 97088 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2019-01-21 | 2019-01-23 | 73016 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2023-08-14 | 2023-12-14 | 201801 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2023-08-14 | 2023-11-28 | 201805 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2021-07-05 | 2021-09-22 | 141860 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2019-02-19 | 2019-05-22 | 76311 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2018-11-01 | 2019-02-16 | 65967 |
| BYSTOLIC | 20.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84755 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2023-10-11 | 2023-11-23 | 206797 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-12-09 | 2023-01-19 | 177700 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-27 | 163730 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
| BYSTOLIC | 20MG | TABLET | Resolved | 2022-01-20 | 2022-09-01 | 153204 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2018-12-05 | 2019-02-08 | 68675 |
| BYSTOLIC | 5MG | TABLET | Resolved | 2024-10-15 | 2025-01-17 | 240134 |
| BYSTOLIC | 5MG | TABLET | Resolved | 2022-03-17 | 2022-06-30 | 156945 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84758 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-06 | 84746 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACULAR LS | 0.4% | SOLUTION | To be discontinued | 2025-01-23 | 2025-01-23 | 248365 |
| ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
| HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
| HUMIRA VIAL | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
| LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
| MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
| MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
| MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
| NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
| SKYRIZI | 75MG | SOLUTION | Discontinued | 2025-01-27 | 2025-02-06 | 248607 |
| TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
| VIBERZI | 75MG | TABLET | To be discontinued | 2022-03-23 | 2025-09-02 | 157156 |
| VIBERZI | 100MG | TABLET | Reversed | 2022-03-23 | 2022-06-22 | 157159 |
Showing 1 to 13 of 13